Direx Group
Direx Group is an Israeli medical device company that develops and sells non-invasive shockwave therapy systems for urology, men's health, women's health, musculoskeletal, vascular, and aesthetic applications to hospitals and clinics across more than six countries.
- Company typePrivate
- Founded1980
- HeadquartersCanton, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Direx Group does
Direx Group is an Israeli medical technology company founded in the 1980s that develops and manufactures non-invasive shockwave therapy systems used in urology, men's health, women's health, musculoskeletal, vascular, and aesthetic applications. The company's product portfolio spans two categories: the Morenova family of low-intensity shockwave therapy (LISWT) systems, which includes Tabletop, Pro, High Energy, and Home variants, and the high-energy Duet Magna, Integra, and Renova systems for kidney stone lithotripsy and erectile dysfunction treatment. Underlying technologies include proprietary Linear Shockwave Technology for full organ coverage, electromagnetic dual-shockwave architectures, and DICOM3/PACS imaging integration on the Integra lithotripter. The company emphasizes pain-free, drug-free treatment modalities and reports no adverse events across its clinical compendium.
The business operates as a hardware vendor, selling medical devices directly to hospitals, urology clinics, and multi-specialty healthcare providers through an enterprise field sales model, supplemented by a sub-dealer channel in China (Taiyuan-based distributor). Notable installed bases include Jianguo Traditional Chinese Medicine Hospital in Wuxi (43M+ shocks delivered since July 2020, 2,000+ patients treated), D Clinic Tokyo and Osaka in Japan, Royal Medical Center Abu Dhabi, and Dr. Cobi Reisman's clinic in Tel Aviv. The company operates through a closely related subsidiary, Initia Ltd., which handles commercial partnerships and is led by CEO Niv Ein-Gal. Pricing is quote-based and not publicly disclosed; no revenue, headcount, or funding figures are available. The company is privately held and self-describes 40+ years of continuous operation originating with one of the earliest lithotripters commercially available.
Direx Group firmographics
Firmographics- Name
- Direx Group
- Legal name
- Direx Group
- Website
- https://direxgroup.com
- Company type
- Private
- Founded year
- 1980
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Direx Group is an Israeli medical device company that develops and sells non-invasive shockwave therapy systems for urology, men's health, women's health, musculoskeletal, vascular, and aesthetic applications to hospitals and clinics across more than six countries.
- Ownership category
- akta.pro rank
Direx Group industry classification
Industry- Product category
- Shockwave Therapy Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Kidney Stone Management & Lithotripsy Devices (HLAHAKAI)
- akta.pro secondary industry
- Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG)
Keywords
Where Direx Group is headquartered
LocationHeadquarters
- HQ city
- Canton
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Direx Group business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- Medical Device Sales: Direx Group generates revenue through the sale of shockwave therapy medical devices including Morenova, Duet Magna, Integra, and Renova systems to healthcare providers, hospitals, and clinics worldwide.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Direx Group product offering
Product offeringCore offering
Direx Group designs, develops, manufactures, and sells shockwave therapy medical devices to hospitals, clinics, and healthcare providers worldwide. The product portfolio spans the Morenova family of low-intensity shockwave therapy (LISWT) systems for men's health, women's health, musculoskeletal, vascular, kidney disease, esthetics, and alopecia indications, alongside high-energy lithotripsy systems (Duet Magna, Integra) for kidney stone treatment and Renova, the first dedicated shockwave system for erectile dysfunction using Linear Shockwave Therapy.
Product overview
Direx Group offers a comprehensive portfolio of shockwave therapy medical devices spanning both low-intensity (Morenova family) and high-energy (Duet Magna, Integra, Renova) systems. The Morenova family provides next-generation LISWT technology for diverse applications including women's health (urinary incontinence, sexual dysfunction), men's health (erectile dysfunction, Peyronie's disease, chronic prostatitis), vascular disease, kidney disease, alopecia, esthetics, and musculoskeletal disorders. The high-energy solutions include Duet Magna and Integra for kidney stone lithotripsy, and Renova as the first dedicated shockwave system for erectile dysfunction treatment using Linear Shockwave Therapy.
Differentiator
Problem solved
Functional benefit
Brands
- Morenova: Next generation low-intensity shockwave therapy (LISWT) technology platform offering treatment for various medical conditions including women's health, men's health, vascular disease, kidney disease, alopecia, esthetics, and musculoskeletal disorders
- Duet Magna
- Integra
- Renova
Products and services
- Morenova Family (LISWT Platform) Next-generation low-intensity shockwave therapy (LISWT) technology platform offering safe, affordable, and pain-free treatment solutions across women's health, men's health, vascular disease, kidney disease, alopecia, esthetics, and musculoskeletal disorders, sold to healthcare providers.
- Morenova Tabletop
Quantifiable outcome
- 43 million+ shockwaves delivered with consistent system performance over 4+ years of continuous operation
- +3 more outcomes
Companies that use Direx Group
Customer profileNamed customers9 records
Segments8 records
Ideal customer profiles2 records
Direx Group technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature5 records
Direx Group partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and major.
- Shanghai Taiyuan Life Science Ltd. (China)coreStrategic partnership for expanding shockwave therapy market in China. Nearly 10 years of collaboration, notably launching the Renova shockwave therapy system for erectile dysfunction in China with market-leading position. Focus areas include urology devices, ED therapy, orthopedic pain management, female sexual dysfunction, stress urinary incontinence, chronic wound healing, overactive bladder, and chronic kidney disease. Clinical trials expected to begin before end of 2025.
- Royal Medical Center Abu Dhabi (UAE)core3-day on-site intensive training for Morenova Low Intensity Shockwave device. Multi-disciplinary exchange covering men's health (ED, PD, CPPS), women's health (SUI, FSD, OAB), orthopedics (MSDs), aesthetics (cellulite, stretch marks), and wound care (PAD). Live demonstrations and training conducted by product manager Jwana Akawe.
- Sapporo Medical University Hospital (Japan)majorGroundbreaking clinical study by Urological Department utilizing Renova treatment protocol. First-of-its-kind study investigating histological effects of Li-ESWT on corpus cavernosum. Renova employs Li-ESWT to promote angiogenesis and improve blood flow in the penis.
- D Clinic Tokyo and D Clinic Osaka (Japan)majorTwo clinical trial sites for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) under guidance of Dr. Akira Tsujimura, Professor at Juntendo University Urayasu Hospital. Led by Dr. Taro Koyama (Tokyo) and Dr. Yoshihiro Yasuda (Osaka).
- Dr. Cobi Reisman (Israel/Netherlands)coreCollaboration with renowned urology and sexual health expert, founder of European Training and Certification Program in Sexual Health and Sexual Therapy, former President of European Society for Sexual Health (ESSM). Dr. Reisman brings expertise to MoreNova at his clinic in Tel Aviv-Yafo, treating ED, chronic pelvic pain, Peyronie's disease, and women's health conditions.
- Jianguo Traditional Chinese Medicine Hospital (Wuxi, China)majorPrivate hospital specializing in andrology that has operated Renova system since July 2020, achieving 43 million+ shockwaves delivered and treating over 2,000 patients. System supplied through sub-dealer in Taiyuan.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Direx Group competitors and assessment
Company assessmentBroad incumbents
- Boston Scientific: Large diversified medical device company offering urology products including stone management solutions (lithotripsy, ureteroscopy). While not focus-built shockwave specialist, Boston Scientific competes for hospital urology budgets and may expand into LISWT indications.
- Chattanooga (DJO): DJO Global's Chattanooga division offers physical therapy and rehabilitation equipment including shockwave therapy devices. Competes with Direx's Morenova platform in musculoskeletal and orthopedic applications within rehabilitation medicine.
- EDAP TMS: French medical device company specializing in therapeutic ultrasound and urology, including high-intensity focused ultrasound (HIFU) for prostate conditions and lithotripsy systems. Overlaps with Direx's urology-focused product lines.
- Karl Storz: German endoscopy and surgical device manufacturer with significant urology presence, including ureteroscopy and related stone management products. Competes with Direx indirectly in urology, where endoscopy competes with ESWL for certain kidney stone cases.
Direct peers
- BTL Industries: Czech-based manufacturer of shockwave therapy devices (focused, radial, and planar) for aesthetic, physiotherapy, andrology, and orthopedics applications. Competes directly with the Morenova platform across ED, women's health, and musculoskeletal indications.
- Zimmer MedizinSysteme: German medical device company offering focused and radial shockwave therapy systems primarily for orthopedic, sports medicine, and aesthetic applications. Direct competitor to Direx's Morenova systems in musculoskeletal and general shockwave therapy markets.
- Dornier MedTech: German-headquartered medical device company specializing in lithotripsy systems for urology, including ESWL and laser-based stone management. Direct competitor to Direx's Duet Magna and Integra ESWL product families, particularly in hospital urology departments.
- Storz Medical: Swiss-based pioneer in shockwave therapy and lithotripsy systems, offering both ESWL for kidney stones and focused/diffuse/radial shockwave therapy for orthopedic and aesthetic applications. Directly competes with Direx across both lithotripsy (Duet Magna, Integra) and LISWT (Morenova) product lines.
- Gymna: Belgian manufacturer of medical devices including shockwave therapy systems (radial shockwave) for physiotherapy, orthopedics, and aesthetic applications. Direct competitor in the broader shockwave therapy market Direx addresses with Morenova systems.
- Richard Wolf: German manufacturer of urology and endoscopy equipment, including ESWL systems. Overlaps with Direx's Duet Magna and Integra lithotripsy offerings, particularly in hospitals and urology centers requiring integrated stone management solutions.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Direx Group social profiles
Digital presenceDirex Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Direx Group leadership team
Management profileNumber of profiles
Profiles2 records
Direx Group subsidiaries and ownership
Company hierarchySubsidiaries1 record
Direx Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Direx Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Direx Group
What does Direx Group do?
Direx Group designs, develops, manufactures, and sells shockwave therapy medical devices to hospitals, clinics, and healthcare providers worldwide. The product portfolio spans the Morenova family of low-intensity shockwave therapy (LISWT) systems for men's health, women's health, musculoskeletal, vascular, kidney disease, esthetics, and alopecia indications, alongside high-energy lithotripsy systems (Duet Magna, Integra) for kidney stone treatment and Renova, the first dedicated shockwave system for erectile dysfunction using Linear Shockwave Therapy.
Is Direx Group a public or private company?
Direx Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Direx Group founded?
Direx Group was founded in 1980. It employs 51 to 100 people.
Where is Direx Group based?
Direx Group is headquartered in Canton, United States, in the North America region.
How does Direx Group make money?
One revenue line is on record: medical Device Sales.
Who are Direx Group's main competitors?
Broad incumbents on record are Boston Scientific, Chattanooga (DJO), EDAP TMS and Karl Storz. Direct peers are BTL Industries, Zimmer MedizinSysteme, Dornier MedTech, Storz Medical, Gymna and Richard Wolf.
Does Direx Group have an API?
No public API is recorded for Direx Group.
What industry is Direx Group in?
Direx Group's product category is Shockwave Therapy Medical Devices. Its primary akta.pro industry code is HLAHAKAI, Kidney Stone Management & Lithotripsy Devices, with a secondary code of HLAHABAG, Interventional Radiology & Image-Guided Therapy Systems. Its NAICS code is 334510 and its SIC code is 3841.